Snaith J - Search Results

1

Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies.

Shah VN, Agesen RM, Bardtrum L, Christiansen E, Snaith J, Greenfield JR. Shah VN, et al. Among authors: snaith j. J Diabetes Sci Technol. 2024 Dec 24:19322968241305647. doi: 10.1177/19322968241305647. Online ahead of print. J Diabetes Sci Technol. 2024. PMID: 39717993 Free PMC article.

2

Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?

Snaith JR, Holmes-Walker DJ, Greenfield JR. Snaith JR, et al. Trends Endocrinol Metab. 2020 Feb;31(2):150-164. doi: 10.1016/j.tem.2019.11.007. Epub 2019 Dec 7. Trends Endocrinol Metab. 2020. PMID: 31822381 Review.

3

Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?

Snaith JR, Greenfield JR. Snaith JR, et al. Med J Aust. 2022 Aug 1;217(3):126-128. doi: 10.5694/mja2.51637. Epub 2022 Jun 30. Med J Aust. 2022. PMID: 35772726 Free PMC article. No abstract available.

4

Prescribing patterns of adjunctive therapy for the treatment of type 1 diabetes mellitus among Australian endocrinologists.

Forner P, Snaith J, Greenfield JR. Forner P, et al. Among authors: snaith j. Intern Med J. 2023 Dec 29. doi: 10.1111/imj.16312. Online ahead of print. Intern Med J. 2023. PMID: 38158765

5

Can Unmet Needs Be Addressed by Adjunctive Therapies? Findings from a Patient Perspectives Survey in Adults with Type 1 Diabetes.

Lamaro BD, Greenfield JR, Snaith JR. Lamaro BD, et al. Among authors: snaith jr. J Patient Exp. 2024 May 25;11:23743735241257811. doi: 10.1177/23743735241257811. eCollection 2024. J Patient Exp. 2024. PMID: 38799027 Free PMC article.

6

Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial.

Frampton R, Snaith JR, Hocking S, Holmes-Walker J, Olsen N, Greenfield JR. Frampton R, et al. Among authors: snaith jr. Diabet Med. 2024 Oct;41(10):e15377. doi: 10.1111/dme.15377. Epub 2024 Jun 9. Diabet Med. 2024. PMID: 38853340

7

Excess mortality and cardiovascular disease risk in type 1 diabetes.

Snaith JR, Holmes-Walker DJ, Girgis CM, Greenfield JR. Snaith JR, et al. Lancet. 2019 Mar 9;393(10175):984-985. doi: 10.1016/S0140-6736(18)33050-2. Lancet. 2019. PMID: 30860047 No abstract available.

8

Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664.

Snaith JR, Holmes-Walker DJ, Greenfield JR. Snaith JR, et al. Diabetes Care. 2019 Aug;42(8):e135-e136. doi: 10.2337/dc19-0730. Diabetes Care. 2019. PMID: 31332031 No abstract available.

9

Letter to the Editor: "Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry".

Snaith JR, Holmes-Walker DJ, Greenfield JR. Snaith JR, et al. J Clin Endocrinol Metab. 2020 Oct 1;105(10):dgaa383. doi: 10.1210/clinem/dgaa383. J Clin Endocrinol Metab. 2020. PMID: 32556193 No abstract available.

10

COVID-19: it's changed us.

Snaith JR, Greenfield JR. Snaith JR, et al. Intern Med J. 2020 Sep;50(9):1162-1163. doi: 10.1111/imj.14968. Epub 2020 Aug 6. Intern Med J. 2020. PMID: 32761942 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters